Joined June 2020
- Tweets 21
- Following 120
- Followers 37
- Likes 32
Photos and videos
Abraham Olvera retweeted
29 Oct 2024
Congratulations to the 2024 Dawkins and Strutt grant winners: Mr Alasdair Warwick and Dr @abraham_olvera1🌟 #medresearchawards @Moorfields
1
1
148
Abraham Olvera retweeted
26 Jan 2024
So proud of our team! Recognising changes on OCT is step 1, making the correct call is step 2. watch this space!such a pleasure to work with the brilliant @h_a_khalid, @sktywagner, @LimoliCeleste @LaxmiDRaja @pearsekeane, @AugenarztDrBolz @LukeNic17 and others
26 Jan 2024
👁️New study from @Moorfields calls for full investigation of systemic disease links for patients with PAMM lesions in largest multi-ethnic cohort to date.
🔎In @AJOphthalmology
Led by @LimoliCeleste @LaxmiDRaja & @pearsekeane @h_a_khalid @JosefHuemer1
bit.ly/3SfuCO1
3
7
29
1,932
Abraham Olvera retweeted
18 Dec 2023
Multicenter study led by @JavierZarranz @hospitalclinic highlights relevance of macular neovascularization type on clinical outcomes in wet AMD and reports differences in visual acuity & lesion activity at 1 y. @RetinaSERV @Club_Esp_Macula @FRB_Research ow.ly/hKKQ50Q7wP2
6
26
2,658
Abraham Olvera retweeted
6 Dec 2023
Our review on tele ophthalmology for retinal diseases is out: link.springer.com/content/pd… Great work led by Jonathan Than and Peng Sim from @Moorfields, with contributions from @Swankang, Danson Muttuvelu, @danielferraz1 and Victor Koh.
1
16
563
Abraham Olvera retweeted
30 Nov 2023
Excited to share my work reviewing the next challenges facing AI in DR screening!
25 Nov 2023
Screening programs play a critical role in preventing complications of diabetic retinopathy, and the efficacy of these programs can be enhanced through artificial intelligence (AI). buff.ly/3SRzbjO
1
3
241
Abraham Olvera retweeted
21 Nov 2023
Lack of adoption of ocular imaging standards (DICOM) is bad for research & clinical care.
@NatEyeInstitute @US_FDA @ONC_HealthIT have developed a roadmap for interoperability together. We will consider this strongly in future research grants
@AAOjournal: sciencedirect.com/science/ar…
ALT Three-frame meme involving characters from Spider-Man movie. Top frame: Mary Jane tells Peter "tell me the truth ... I'm ... I'm ready to hear it". Middle frame: Peter responds "ocular imaging devices will be far more useful for clinical care and research if they adopt the DICOM standard". Bottom frame: Mary Jane cries.
12
55
5,486
15 Nov 2023
Kathryn Willis leads a methods paper to explore how individuals with diabetes and NHS staff perceive AI-assisted diabetic eye screening.
A crucial step towards enhancing diabetic eye care with AI.📊👁️🤖
@SGUL_PHRI
tinyurl.com/perception-ai
1
3
221
11 Nov 2023
👁🗨Our latest study offering DR transition probabilities, unveils determinants of sight-threatening DR. By recognising ethnic and age disparities, it underscores the importance of personalised risk stratification in diabetic eye screening.
🤖Learn more: tinyurl.com/arias-dr-screen
1
1
5
241
11 Nov 2023
🔗Further work from the group showed persistence of disparities even among individuals deemed "low-risk" for sight-threatening DR, suggesting potential exacerbation of health inequalities with extended diabetic eye screening intervals.
👁️: tinyurl.com/arias-two-year
1
2
148
Abraham Olvera retweeted
1 Nov 2023
Watch @sktywagner on Germany's national broadcatser @ZDF as the AI Safety Summit begins.
Highlights AI research breakthroughs for patient benefit @Moorfields @UCLeye @uhbtrust enabled by INSIGHT. With @JosefHuemer1
👇Click to watch and read the story bit.ly/40mBpsZ
2
9
33
5,275
25 Oct 2023
Our recent study explored the impact of biennial vs annual DR screening in a diverse population. Biennial screening could delay detection of ~half of STDR cases, particularly among certain population subgroups, potentially leading to health inequalities
bjo.bmj.com/content/early/20…
8
157
Abraham Olvera retweeted
23 Oct 2023
🔬 New Research Alert:
A new publication led by Claudia Liang Peng. The first report of bilateral non-vasogenic cystoid macular oedema and outer retinal columnar abnormalities (ORCA) in the context of dense deposit disease:
journals.lww.com/retinalcase…
1
3
3
577
Abraham Olvera retweeted
13 Sep 2023
1/
🚨🚨 New paper alert 🚨🚨
Introducing RETFound, a foundation model for ophthalmology
We’re super excited about this and hope it will act as a #Cornerstone for global efforts to prevent blindness through #AI
@UCLeye @Moorfields
#OpenAccess @Nature
nature.com/articles/s41586-0…
45
242
659
362,927
Abraham Olvera retweeted
17 Oct 2022
Out now on @BMJ_Ophth 📣
Our study, led by @abraham_olvera1, analysing the prevalence of visual impairment compared to certification of visual impairment (CVI) in patients with diabetic retinopathy (DR).
bjo.bmj.com/content/early/20…
1
3
5
Abraham Olvera retweeted
29 Jul 2022
Adnan Tufail @adnan_tufail1 et al. @Moorfields @UWMedicine examine whether sociodemographic and ocular factors relate to optical coherence tomography–derived foveal curvature in healthy individuals.
doi.org/10.1167/iovs.63.8.26
2
6
Abraham Olvera retweeted
23 May 2022
This was fun! We used code-free deep learning to train an algorithm to detect clinical significant posterior capsule opacification (PCO). This 🇦🇹🇬🇧collaboration between @Moorfields and Hanusch Hospital has been published now bmjophth.bmj.com/content/7/1…. 🥳 1/
2
8
24
28 Apr 2022
Now published:
Estimating excess visual loss from neovascular age-related macular degeneration in the UK during the COVID-19 pandemic: a retrospective clinical audit and simulation model bmjopen.bmj.com/content/12/4…
Well done @AlasdairWarwick, Darren Thomas. @RetinaDiscovery
5
10
Abraham Olvera retweeted
7 May 2021
A wonderful piece of art created by a @GreatOrmondSt patient who was born with #cataract and had surgery as a baby - beautifully framed and ready to hang in our new #SightAndSound building #Paedsrocks
6
37
249
Abraham Olvera retweeted
4 May 2021
A big data analysis study on 15,810 eyes shows improvement in functional visual acuity over the past decade in AMD patients, but the data reveals suboptimal treatment patterns over the years. @RetinaDiscovery @Moorfields ow.ly/rdR150EC4g3
4
9
9 Jun 2020
A fantastic publication with a strong public health message on the impact of treatment delay for neovascular #AMD and visual loss during the COVID-19 pandemic. Result of an outstanding joint effort from all the @RetinaDiscovery Group.
8 Jun 2020
medrxiv.org/content/10.1101/… Just published. Almost 3/4 of new wet #AMD patients are not coming to the hospital for treatment which, according to our group's model, will result in a 50% increase in severe sight impairment. We must reach out to these patients to get them treated.
1
4